焦虑的鱼跃医疗：血压计失准、业绩双降，“千亿市值”梦碎？｜BUG

Core Viewpoint - The article highlights the issues surrounding the accuracy of Yuwell's blood pressure monitors, which have led to consumer dissatisfaction and declining financial performance for Yuwell Medical, the parent company. Financial Performance - Yuwell Medical reported a revenue of 6.028 billion yuan for the first nine months of 2024, a year-on-year decline of 9.53% [10] - The net profit for the same period was 1.532 billion yuan, down 30.09% year-on-year, while the net profit after deducting non-recurring items was 1.274 billion yuan, a decrease of 23.74% [10] - The company’s market capitalization as of March 31, 2025, was 34.966 billion yuan, significantly below its target of 100 billion yuan in revenue and 1 trillion yuan in market value by 2025 [11] Consumer Feedback - A survey on Weibo indicated that 50.4% of respondents believed Yuwell's blood pressure monitors were "not very accurate" or "completely inaccurate," while only 5.5% found them "very accurate" [1] - Consumers reported significant discrepancies in blood pressure readings, with some experiencing measurement errors as high as 20-30 mmHg [4][5] Company Background - Yuwell Medical was founded in 1998 and has grown through a series of acquisitions, expanding its product range to include over 600 types of medical devices [6][7] - The company has faced increasing scrutiny over product quality, with numerous complaints and regulatory penalties in recent years [8] Strategic Challenges - The company is experiencing a decline in revenue and profit, attributed to a saturated market and increased competition in the medical device sector [2][10] - Yuwell Medical's R&D expenditure as a percentage of revenue is relatively low at 6.26%, ranking 48th among 59 listed healthcare equipment companies, indicating a potential weakness in innovation [10] Future Outlook - Yuwell Medical aims to focus on core business areas such as respiratory therapy, diabetes care, and home testing, while emphasizing innovation and R&D to drive future growth [10]